Outcomes of Patients with Myeloproliferative Neoplasms (MPN) after Interferon-Alpha (IFN) Therapy Discontinuation

被引：0
|
作者：
Soret, Juliette
Cassinat, Bruno
Chevret, Sylvie
Dosquet, Christine
Giraudier, Stephane
Verger, Emmanuelle
Maslah, Nabih
Parquet, Nathalie
Chomienne, Christine
Kiladjian, Jean-Jacques
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3106.3106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3106
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Transplant Outcomes for Patients with Secondary Acute Myeloid Leukemia (AML) Arising From Myeloproliferative Neoplasms (MPN)
    Shah, Mithun Vinod
    Saliba, Rima M.
    Ciurea, Stefan O.
    Oran, Betul
    Olson, Amanda
    Bose, Prithviraj
    Bashir, Qaiser
    Ahmed, Sairah
    Alousi, Amin M.
    Mehta, Rohtesh S.
    Pemmaraju, Naveen
    Verstovsek, Srdan
    Popat, Uday R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S322 - S323
  • [42] Adverse reactions of interferon-alpha (IFN-alpha) in patients with chronic myeloid leukemia.
    Hasford, J
    Puosi, F
    Ansari, H
    Hochhaus, A
    Hehlmann, R
    BLOOD, 1997, 90 (10) : 3992 - 3992
  • [43] Hematological Improvement during Deferasirox Treatment in Patients with Myeloproliferative Neoplasms (MPN)
    Latagliata, Roberto
    Montagna, Chiara
    Di Veroli, Ambra
    Porrini, Raffaele
    Crescenzi, Sabrina Leonetti
    Niscola, Pasquale
    Ciccone, Fabrizio
    Spadea, Antonio
    Breccia, Massimo
    Rago, Angela
    Spirito, Francesca
    Cedrone, Michele
    De Muro, Marianna
    Montanaro, Marco
    Andriani, Alessandro
    Bagnato, Antonino
    Lo Coco, Francesco
    Montefusco, Enrico
    Alimena, Giuliana
    BLOOD, 2014, 124 (21)
  • [44] Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms
    Teng, Guangshuai
    Zhang, Yuhui
    Du, Chenxiao
    Wang, Yan
    Hu, Naibo
    Han, Yingdi
    Ma, Jinyu
    Gao, Shan
    Xiang, Guangpeng
    Shao, Zonghong
    Bai, Jie
    BLOOD, 2022, 140 : 3959 - 3960
  • [45] ANTIBODIES TO INTERFERON-ALPHA IN PATIENTS
    ANTONELLI, G
    DIANZANI, F
    ARCHIVES OF VIROLOGY, 1993, : 271 - 277
  • [46] TREATMENT OF HAIRY-CELL LEUKEMIA WITH INTERFERON-ALPHA(IFN-ALPHA) - BEFORE OR AFTER SPLENECTOMY
    PORZSOLT, F
    DIGEL, W
    HEIL, G
    BARTRAM, CR
    RAGHAVACHAR, A
    KERN, W
    SEIFRIED, E
    RAGHAVACHAR, A
    HEIMPEL, H
    BLUT, 1986, 53 (03): : 213 - 213
  • [47] IS INTERFERON-ALPHA REALLY DEAD AS THERAPY FOR MULTIPLE MYELOMA PATIENTS?
    Levi, A.
    Russo, E.
    Za, T.
    Federico, V.
    Pisani, F.
    Siniscalchi, A.
    Gentilini, F.
    Bossa, M.
    Caravita, T.
    De Stefano, V.
    Foa, R.
    Petrucci, M.
    HAEMATOLOGICA, 2012, 97 : 621 - 622
  • [48] Choice of ukrain and interferon-alpha doses for the cancer patients therapy
    Voltchek, I
    Sologub, T
    Gontcharova, L
    Pokrovskaya, L
    Belozyorova, L
    Lamanova, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S20 - S20
  • [49] Autoimmune thyroid disease in patients with chronic hepatitis B (HB) and hepatitis C (HC) before and after interferon-alpha (IFN) therapy.
    Marek, Bogdan
    Kajdaniuk, Dariusz
    Janczewska-Kazek, Ewa
    Kos-Kudla, Beata
    Piska, Lucyna Siemin
    Nowak, Mariusz
    Borgiel-Marek, Halina
    Ostrowska, Zofia
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A108 - A108
  • [50] Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha
    Murphy, Philip T.
    McPherson, Suzanne
    Langabeer, Stephen E.
    ANNALS OF HEMATOLOGY, 2011, 90 (02) : 233 - 234
12345